ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Skin protection by use of sucralfate cream during external beam radiotherapy for breast cancer: a prospective double blind randomized phase II study
European Journal of Cancer
◽
10.1016/s0959-8049(01)81832-3
◽
2001
◽
Vol 37
◽
pp. S360
Author(s):
C. Gutierrez
◽
S. Villa
◽
V. Navarro
◽
A. Lucas
◽
F. Moreno
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
External Beam Radiotherapy
◽
External Beam
◽
Skin Protection
◽
Double Blind
◽
Randomized Phase Ii
Download Full-text
Related Documents
Cited By
References
Phase II Study of Concurrent Capecitabine and External Beam Radiotherapy for Pain Control of Bone Metastases of Breast Cancer Origin
PLoS ONE
◽
10.1371/journal.pone.0068327
◽
2013
◽
Vol 8
(7)
◽
pp. e68327
◽
Cited By ~ 3
Author(s):
Yulia Kundel
◽
Nicola J. Nasser
◽
Ofer Purim
◽
Rinat Yerushalmi
◽
Eyal Fenig
◽
...
Keyword(s):
Breast Cancer
◽
Bone Metastases
◽
Phase Ii
◽
Pain Control
◽
Phase Ii Study
◽
External Beam Radiotherapy
◽
External Beam
Download Full-text
Letrozole Versus Letrozole plus Lapatinib (GW572016) in Hormone-Sensitive, HER2-Negative Operable Breast Cancer: A Double-Blind, Randomized, Phase II Study with Biomarker Evaluation (EGF109077-LAP107692/LETLOB)
Clinical Breast Cancer
◽
10.3816/cbc.2008.n.010
◽
2008
◽
Vol 8
(1)
◽
pp. 97-100
◽
Cited By ~ 12
Author(s):
Antonio Frassoldati
◽
Valentina Guarneri
◽
Federico Piacentini
◽
Gordana Jovic
◽
Simona Giovannelli
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Operable Breast Cancer
◽
Double Blind
◽
Randomized Phase Ii
◽
Hormone Sensitive
◽
Biomarker Evaluation
Download Full-text
Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study
Investigational New Drugs
◽
10.1007/s10637-010-9538-8
◽
2010
◽
Vol 30
(2)
◽
pp. 681-687
◽
Cited By ~ 28
Author(s):
Katalin Boér
◽
István Láng
◽
Antonio Llombart-Cussac
◽
Inger Andreasson
◽
Guillermo L. Vivanco
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
◽
Line Treatment
◽
Second Line
◽
Double Blind
◽
Double Blind Placebo
◽
Randomized Phase Ii
Download Full-text
Faculty of 1000 evaluation for Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer.
F1000 - Post-publication peer review of the biomedical literature
◽
10.3410/f.718021759.793480257
◽
2013
◽
Author(s):
Ana Maria Gonzalez-Angulo
Keyword(s):
Breast Cancer
◽
Progesterone Receptor
◽
Phase Ii
◽
Phase Ii Study
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
◽
Randomized Phase Ii
◽
Positive Breast Cancer
Download Full-text
Faculty of 1000 evaluation for A Double-Blind, Randomized Phase II Study to Evaluate the Safety and Efficacy of Acetyl-L-Carnitine in the Prevention of Sagopilone-Induced Peripheral Neuropathy.
F1000 - Post-publication peer review of the biomedical literature
◽
10.3410/f.718136956.793486581
◽
2013
◽
Author(s):
Steve Plaxe
◽
Kristy Ward
Keyword(s):
Peripheral Neuropathy
◽
Phase Ii
◽
Phase Ii Study
◽
Double Blind
◽
Safety And Efficacy
◽
Randomized Phase Ii
Download Full-text
Faculty Opinions recommendation of Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.734565867.793581155
◽
2020
◽
Author(s):
David Potter
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
Neoadjuvant Therapy
◽
Early Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Randomized Phase Ii
◽
Estrogen Receptor Positive
Download Full-text
346 Taxol or doxorubicin as first line chemotherapy in advanced breast cancer (ABC). A prospective randomized phase II study with crossover
European Journal of Cancer
◽
10.1016/0959-8049(95)95599-2
◽
1995
◽
Vol 31
◽
pp. S75
◽
Cited By ~ 1
Author(s):
R. Paridaens
◽
P. Bruning
◽
F. Calabresi
◽
A. Awada
◽
J.A. Roy
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
◽
First Line
◽
Randomized Phase Ii
◽
Line Chemotherapy
Download Full-text
Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study
Annals of Oncology
◽
10.1093/annonc/mdx505
◽
2018
◽
Vol 29
(1)
◽
pp. 154-161
◽
Cited By ~ 70
Author(s):
H.S. Han
◽
V. Diéras
◽
M. Robson
◽
M. Palácová
◽
P.K. Marcom
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Randomized Phase Ii
◽
Locally Recurrent
Download Full-text
Randomized phase II study of single-agent epirubicin +/— verapamil in patients with advanced metastatic breast cancer
Annals of Oncology
◽
10.1093/oxfordjournals.annonc.a058356
◽
1993
◽
Vol 4
(1)
◽
pp. 45-50
◽
Cited By ~ 35
Author(s):
K. Mross
◽
C. Bohn
◽
L. Edler
◽
W. Jonat
◽
W. Queisser
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Single Agent
◽
Metastatic Breast
◽
Randomized Phase Ii
Download Full-text
START: A randomized phase II study in patients with triple negative, androgen receptor positive locally recurrent (unresectable) or metastatic breast cancer treated with darolutamide or capecitabine (UCBG-306)
Annals of Oncology
◽
10.1093/annonc/mdy272.356
◽
2018
◽
Vol 29
◽
pp. viii120
◽
Cited By ~ 1
Author(s):
H. Bonnefoi
◽
C. Levy
◽
G. MacGrogan
◽
T. Grellety
◽
B. Asselain
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Androgen Receptor
◽
Phase Ii
◽
Triple Negative
◽
Phase Ii Study
◽
Metastatic Breast
◽
Randomized Phase Ii
◽
Locally Recurrent
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close